Biosynthetic Pathways of Tryptophan Metabolites in Saccharomyces cerevisiae Strain: Insights and Implications.
Study Design
- 研究类型
- In vitro
- 干预措施
- Biosynthetic Pathways of Tryptophan Metabolites in Saccharomyces cerevisiae Strain: Insights and Implications. None
- 对照组
- Placebo
- 效应方向
- Positive
- 偏倚风险
- Unclear
Abstract
Tryptophan metabolites, such as 5-hydroxytryptophan (5-HTP), serotonin, and melatonin, hold significant promise as supplements for managing various mood-related disorders, including depression and insomnia. However, their chemical production via chemical synthesis and phytochemical extraction presents drawbacks, such as the generation of toxic byproducts and low yields. In this study, we explore an alternative approach utilizing S. cerevisiae STG S101 for biosynthesis. Through a series of eleven experiments employing different combinations of tryptophan supplementation, Tween 20, and HEPES buffer, we investigated the production of these indolamines. The tryptophan metabolites were analyzed using liquid chromatography with tandem mass spectrometry (LC-MS/MS). Notably, setups replacing peptone in the YPD media with tryptophan (Run 3) and incorporating tryptophan along with 25 mM HEPES buffer (Run 4) demonstrated successful biosynthesis of 5-HTP and serotonin. The highest 5-HTP and serotonin concentrations were 58.9 ± 16.0 mg L-1 and 0.0650 ± 0.00211 mg L-1, respectively. Melatonin concentrations were undetected in all the setups. These findings underscore the potential of using probiotic yeast strains as a safer and conceivably more cost-effective alternative for indolamine synthesis. The utilization of probiotic strains presents a promising avenue, potentially offering scalability, sustainability, reduced environmental impact, and feasibility for large-scale production.
Full Text
Figures
Figure 1
Overview of biosynthetic pathways for tryptophan metabolites in Saccharomyces cerevisiae, mapping the enzymatic steps from tryptophan to downstream bioactive compounds.
diagram
Figure 2
Metabolite profiling data from yeast strains showing differential production of tryptophan derivatives under varying culture conditions.
chart
Figure 3
Gene expression or enzyme activity data for key enzymes in the tryptophan metabolic pathway in engineered Saccharomyces cerevisiae strains.
chart
Figure 4
Comparative analysis of tryptophan metabolite yields across different yeast strain backgrounds, identifying optimal producers for industrial or therapeutic applications.
chartTables
Table 1
| Day 3 | Day 4 | Day 5 | |
|---|---|---|---|
| 108 |
|
|
|
| 109 |
|
|
|
Table 2
| Day 3 | Day 4 | Day 5 | |
|---|---|---|---|
| 108 |
|
|
|
| 109 |
|
|
|
Table 3
| Runs | Peptone: Tryptophan | Tween 20 (%) | HEPES Buffer (mM) |
|---|---|---|---|
| 1 | 100%:0% | 0 | 0 |
| 2 | 50%:50% | 0 | 0 |
| 3 | 0%:100% | 0 | 0 |
| 4 | 0 | 25 | |
| 5 | 0 | 100 | |
| 6 | 0.1 | 0 | |
| 7 | 0.1 | 25 | |
| 8 | 0.1 | 100 | |
| 9 | 0.2 | 0 | |
| 10 | 0.2 | 25 | |
| 11 | 0.2 | 100 |
Table 4
| Microbial Species/Strain | Source | Substrate | Concentrations | Ref. |
|---|---|---|---|---|
| Purchased | YPD medium (with 100% tryptophan and 25 mM HEPES buffer) | 5-HTP = 58.9 ± 16.0 mg L−1 | This study | |
| Purchased | Arginine decarboxylase broth (ADB) | Tryptamine = 0.00 | [ | |
| Tryptamine = 0.00 | ||||
| Tryptamine = 0.00 | ||||
| Tryptamine = 19.6 ± 0.71 mg L−1 broth | ||||
| Purchased | Synthetic must (200 g L−1 reducing sugars + 300 mg N L−1 assimilable nitrogen), more L-tryptophan (1 mM) | 5-HTP = 949 ± 80.3 pg/109 | [ | |
| 5-HTP = 935 ± 25.2 pg/109 | ||||
| Isolated from the roots of Red Globe grape cultivar | 200 mg L−1 of 15N double-labeled L-tryptophan | 15N-5-HTP = 0.0181 ± 0.00114 mg L−1 | [ |
References
- Melatonin and serotonin effects J. Physiol. Pharmacol., 2007
- Enzyme Promiscuity in Serotonin Biosynthesis, From Bacteria to Plants and Humans Front. Microbiol., 2022
- Hippocampal ischaemia from accidental 5-Hydroxytryptophan (5-HTP) overdose case report Clin. Neurol. Neurosurg., 2022
- Statista Total Global Melatonin Supplements Market in 2016 and a Forecast for 2021
- ClinCalc the Top 300 Drugs of 2020
- The Potential of Phytomelatonin as a Nutraceutical Molecules, 2018
- Naturally occurring melatonin: Sources and possible ways of its biosynthesis Compr. Rev. Food Sci. Food Saf., 2020
- Mechanisms of action of probiotics Adv. Nutr., 2019
- Sources, formulations, advanced delivery and health benefits of probiotics Curr. Opin. Food Sci., 2020
- The many faces of Enterococcus spp.—Commensal, probiotic and opportunistic pathogen Microorganisms, 2021
- The genus Enterococcus: Between probiotic potential and safety concerns—An update Front. Microbiol., 2018
- Probiotic strains of Lactococcus lactis subsp. lactis produce neuroactive substances J. Hyg. Eng. Des., 2017
- Lactobacillus Plantarum LRCC5314 Includes a Gene for a Substance that Stimulates the Secretion of Serotonin Res. Sq., 2021
- Endophytic bacterium Pseudomonas fluorescens RG11 may transform tryptophan to melatonin and promote endogenous melatonin levels in the roots of four grape cultivars Front. Plant Sci., 2017
- The function of lactic acid bacteria on biogenic amines production by food-borne pathogens in arginine decarboxylase broth Food Sci. Technol. Res., 2012
- Intracellular biosynthesis of melatonin and other indolic compounds in Saccharomyces and non-Saccharomyces wine yeasts Eur. Food Res. Technol., 2019
- Serotonin Producing Bacteria U.S. Patent, 2022
- Microbe-Based Modulation of Serotonin Biosynthesis U.S. Patent, 2016
- Saccharomyces cerevisiae Exponential Growth Kinetics in Batch Culture to Analyze Respiratory and Fermentative Metabolism J. Vis. Exp. JoVE, 2018
Used In Evidence Reviews
Similar Papers
Journal of sleep research · 2017
European guideline for the diagnosis and treatment of insomnia.
Chronobiology international · 2012
Circadian typology: a comprehensive review.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2017
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
Movement disorders : official journal of the Movement Disorder Society · 2011
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
Cell · 1981
Regulation of terminal differentiation of cultured human keratinocytes by vitamin A.
Journal of neuroendocrinology · 2003